Hence, several anti-inflammatory drugs including complement inhibitors, tumor necrosis factor (TNF)-α inhibitors, and dexamethasone are currently on clinical testing for use in AMD [18]–[21]. This evidence concerns the gene TNF and age-related macular degeneration.